Solos Endoscopy, Inc. (Solos) has received additional purchase orders for its MammoView line of surgical endoscopy instruments from the National Cancer Institute (NCI), as well as the US National Institute of Health (NIOH), which is part of the US Department of Health and Human Services. The company claims that Solos's MammoView system employs advanced micro endoscopes and optical technology to give physicians sharp, clear images of the milk ducts where the majority of breast cancers arise.
The company also claims that Solos’s MammoView line of endoscopy surgical instruments has received positive reviews from various surgeons who have been regularly using the instruments during their endoscopic procedures.
“The cytology retrieval kit which contains miniature brushes and a mini aspirator is, in my opinion, the best method for retrieving cell samples from the lining of the mammary duct,” stated David N. Danforth Jr., M.S., M.D., Surgery Branch Senior Investigator from the National Institute of Health.
“We are very pleased to continue supplying our MammoView(TM) surgical endoscopy instruments to the top cancer care and research organizations in the country. We believe, as the body of research expands, more and more surgeons will utilize our system, which will enable them to detect possible cancerous cells in its early stage and begin treatments immediately on their patients,” stated Bob Segersten, President of Solos.